VITABLUE-WULING SHENBAO PLUS CAPSULE 500MG
VITABLUE-WULING SHENBAO PLUS CAPSULE 500MG : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL05072122TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- VITABLUE SDN BHD
- Manufacturer
- Phytobiotech Sdn. Bhd.
- Registration period starting
- 2022-06-02
- Published validity end
- 2027-06-02
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Wuling Fungus (Xylaria Nigripes) | Wuling Fungus (Xylaria Nigripes)[450;mg;500;mg] | Not identified |
| PANAX QUINQUEFOLIUS | PANAX QUINQUEFOLIUS[50;mg;500;mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Wuling Fungus (Xylaria Nigripes)[450;mg;500;mg],PANAX QUINQUEFOLIUS[50;mg;500;mg]
- Valid until
- 2027-06-02
- Registration date
- 2022-06-02
- Published description
- NATURAL PRODUCT
- Licence holder
- VITABLUE SDN BHD
- Producer
- Phytobiotech Sdn. Bhd.
- Published name
- VITABLUE-WULING SHENBAO PLUS CAPSULE 500MG
- Published reference
- 2004021623497
- Registration number
- MAL05072122TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL05072122TC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- PANAX QUINQUEFOLIUS
Read the warning, when it applies and the studies cited
PANAX QUINQUEFOLIUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or digoxin (Brinker 2010; Dasgupta et al. 2007; Elmer et al. 2007; Yuan et al. 2004).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Dascalu et al. 2007; Vuksan et al. 2000a,b,c).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except Glucose levels and Adaptogen - immune system.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.